Protocol summary

Summary
The aim of this study is to assess the effects of vit E, vit D on serum and follicular fluid MDA, TAC, SOD and oocyte quality and ICSI out comes in infertile pcos women. For this purpose we enroll 100 infertile pcos women who need ICSI in avicenna infertility clinic during 2014-2015.they divide randomly in two groups.group1 receive 400IU vit E per day and 50000 IU vit D biweekly for 2 months and group 2 receive placebo for 2 months.both groups receive nutrition consult and they receive controlled low glycemic diet with balanced antioxidants and reduced trans fat.ICSI protocol is long in all patients. MDA, TAC, SOD are measured in serum twice: at the beginning of the study, before intervention and at the oocyte collection day and in follicular fluid on the oocyte collection day.antioxidant therapy seem to improve oocyte quality and ICSI outcomes due to reduce oxidative stress markers.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2014081018662N1
Registration date: 2014-08-21, 1393/05/30
Registration timing: prospective

Last update:
Update count: 0
Registration date
2014-08-21, 1393/05/30
Registrant information
Name
Farnaz Fatemi
Name of organization / entity
Avicenna Research Institute
Country
Iran (Islamic Republic of)
Phone
+98 21 2243 2020
Email address
f.fatemi@avicenna.ac.ir
Recruitment status
Recruitment complete
Funding source
Avicenna Infertility Clinic
Expected recruitment start date
2014-08-23, 1393/06/01
Expected recruitment end date
2015-03-20, 1393/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effect of supplementation with vitamin E and vitamin D on serum and follicular fluid oxidative and anti oxidative stress factors, oocyte quality and ICSI outcomes in PCOS infertile women candidate for ICSI who referred to Infertility Clinic of Avicenna Research Center during 2014-2015
Public title
Effect of vitamin E, vitamin D on treatment of infertility in PCOS patients
Purpose
Basic scienece
Inclusion/Exclusion criteria
Inclusion criteria: PCOS patients based on ROTERDOM criteria; age:18-38 years old; day3 FSH level less than 12; BMI:20-34. Exclusion criteria: patients with heart, liver or renal disease; patients with Endometriosis; use of anticoagulats: ASA, Heparin, Warfarin; use of antidepresants:Fluoxetin, Certeralin; use of Statins: Levastatin, Atorvastatin; patients with Eye disease: Retinitis pigmentosa; use of anti inflammatory drugs and corticosteroids:prednisolon; use of vitamins and anti oxidants in 3 months ago; vit K deficiency and bleeding disorders; history of chemotherapy or radiotherapy
Age
From 18 years old to 38 years old
Gender
Female
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size: 100
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Avicenna Research Institute Ethics Committee
Street address
Avicenna Research Institute, Shahid Beheshti University, Velenjak Avenue, Chamran highway
City
Tehran
Postal code
1936773493
Approval date
2014-06-24, 1393/04/03
Ethics committee reference number
93/1709

Health conditions studied

1

Description of health condition studied
Polycystic ovarian syndrome
ICD-10 code
E28.2
ICD-10 code description
Sclerocystic ovary syndromeStein-Leventhal syndrome

2

Description of health condition studied
Infertility
ICD-10 code
Z31.2
ICD-10 code description
In vitro fertilization

Primary outcomes

1

Description
serum malondealdehyde
Timepoint
before intervention and after intervention on the oocyte collection day
Method of measurement
American key man kit

2

Description
serum total antioxidant capaity(TAC)
Timepoint
before intervention and after intervention on the oocyte collection day
Method of measurement
American key man kit

3

Description
serum super oxid dismuthase
Timepoint
before intervention and after intervention on the oocyte collection day
Method of measurement
American key man kit

4

Description
follicular fluid malondealdehyde
Timepoint
on the oocyte collection day
Method of measurement
American key man kit

5

Description
follicular fluid total anti oxidant capacity
Timepoint
on the oocyte collection day
Method of measurement
American key man kit

6

Description
follicular fluid super oxid dismuthase
Timepoint
on the oocyte collection day
Method of measurement
American key man kit

Secondary outcomes

1

Description
oocyte quality
Timepoint
on the day of oocyte collection
Method of measurement
morphologic assesment with microscope

2

Description
ICSI outcome
Timepoint
2 weeks after embryo transfer
Method of measurement
serum BHCG

Intervention groups

1

Description
placebo of vit E once daily for 2 months
Category
Treatment - Drugs

2

Description
pearl vit D,Biweekly for 2 months
Category
Treatment - Drugs

3

Description
placebo of vit D,biweekly for 2 months
Category
Treatment - Drugs

4

Description
pearl vit E,400 IU,once daily for 2 months
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Avicenna Infertility Clinic
Full name of responsible person
Dr. Farnaz Fatemi
Street address
No. 97, Yakhchal st., Shariati avenu,Tehran, Iran
City
Tehran

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Avicenna Infertility Clinic
Full name of responsible person
Dr. Mohammad Mehdi Akhondi
Street address
No. 97, Yakhchal st., Shariati avenu,Tehran, Iran
City
Tehran
Grant name
Grant code / Reference number
93/1717
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Avicenna Infertility Clinic
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Avicenna Infertility Clinic
Full name of responsible person
Dr. Farnaz Fatemi
Position
MD,OB & GYN, Infertility fellowship
Other areas of specialty/work
Street address
No. 97, Yakhchal st., Shariati avenu,Tehran, Iran
City
Tehran
Postal code
1941913114
Phone
+98 21 23519
Fax
+98 21 2264 4754
Email
f.fatemi@avicenna.ac.ir
Web page address
www.avicenna.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Avicenna Infertility Clinic
Full name of responsible person
Dr. Farnaz Fatemi
Position
MD, OB & GYN, Infertility fellowship
Other areas of specialty/work
Street address
No. 97, Yakhchal st., Shariati avenu,Tehran, Iran
City
Tehran
Postal code
1941913114
Phone
+98 21 23519
Fax
+98 21 2264 4754
Email
f.fatemi@avicenna.ac.ir
Web page address
www.avicenna.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Avicenna Infertility Clinic
Full name of responsible person
Dr. Farnaz Fatemi
Position
MD,OB & GYN, Infertility fellowship
Other areas of specialty/work
Street address
No. 97, Yakhchal st., Shariati avenu,Tehran, Iran
City
Tehran
Postal code
1941913114
Phone
+98 21 23519
Fax
+98 21 2264 4754
Email
f.fatemi@avicenna.ac.ir
Web page address
www.avicenna.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...